Major win

TrumpRx: GLP-1s from $149, insulin from $35

TrumpRx.gov puts the discounted cash price of popular brand-name drugs on one government website, from GLP-1s to insulin to inhalers.

You can't shop for a price you can't see, and for years the price of a brand-name drug was hidden until the register.

The flag of the United States of America

The shelf tag for medicine: what TrumpRx shows a patient today

Since February, TrumpRx.gov has posted cash prices that came out of the President's drug deals: the Wegovy pill from $149 a month instead of $1,349, Zepbound from $299, and insulins such as Lantus, NovoLog and Tresiba from $35.

Why you should care

CMS Administrator Dr. Mehmet Oz has said that roughly one time in three, a patient leaves the pharmacy without a prescribed medicine because it costs too much. Many of those patients are uninsured, between jobs, stuck below a high deductible, or taking a drug their plan won't cover. For them the cash price is the price. A posted price lets a family plan, compare and decide before standing at the counter with a sick child or a new diagnosis.

What does Wegovy cost? For most of its life the honest answer was a shrug. The list price was $1,349 a month, and unless your plan covered it, you found out your real number at the register.

Walk into any grocery store and look at the little tag under the cereal. It tells you the price per ounce, so you can see in two seconds that the big box beats the small one. Nobody calls that tag a breakthrough, but it lets a family compare before they buy, because the price is right where you can see it.

TrumpRx.gov is that shelf tag for medicine. It opened February 5 with 40 brand-name drugs from the first five companies that signed the President's Most Favored Nation deals. Today it lists 80 drugs under what it calls Presidential deals, and in May it added more than 600 generics through Amazon Pharmacy, Cost Plus Drugs and GoodRx, many priced under $5.

What the tags say

Here is what the site showed on October 11. The Wegovy pill starts at $149 a month, and Foundayo, a newer GLP-1 pill, also starts at $149. The Wegovy and Ozempic pens start at $199. Zepbound starts at $299, against a listed price of $1,087 for the vial. Lantus, NovoLog, Tresiba, Toujeo and several other insulins start at $35. The Bevespi inhaler for COPD is $50.65, down from $458.05.

The White House says patients have saved more than $700 million through the site since launch.

The honest fine print

A common complaint is that TrumpRx mostly surfaces discounts that already existed, and part of that is true. Health policy experts told the Associated Press that many drugs on the site are cheaper through insurance or as generics, and the site itself warns that your copay may be lower. NBC News reported that the site does not connect to insurance or count toward a deductible, and a New York Times review found German prices lower in more than half of 24 comparisons. Many generics on the site were cheap before it existed.

But a discount you cannot find does not help you. And the GLP-1 cash prices on the site came out of the President's November 2025 deals with Eli Lilly and Novo Nordisk, which cut them to a fraction of list. A $149 pill against a $1,349 list price is a negotiated price, not a coupon that was hiding in a drawer.

Not many families have read the tag yet: in a survey NBC reported in March, 7% of adults on prescription drugs had visited the site, and 16% of GLP-1 users. Read it before your next refill. Look up any brand-name drug you pay cash for on TrumpRx.gov, ask your pharmacist what your insurance would charge, and pay the smaller number.

Sources and footnotes

  1. TrumpRx.gov: home page and drug listings (checked Oct. 11, 2026)
  2. White House fact sheet: President Trump launches TrumpRx.gov to bring lower drug prices to American patients (Feb. 5, 2026)
  3. Fox Business: Americans save more than $700M on prescription medications through TrumpRx, White House says (July 24, 2026)
  4. Washington Examiner: Dr. Oz: 1 in 3 Americans leave pharmacy empty-handed over drug costs (Aug. 23, 2026)
  5. Becker's Hospital Review: TrumpRx expands to 600+ generics, taps Amazon Pharmacy and Cost Plus Drugs (May 19, 2026)
  6. Becker's Hospital Review: TrumpRx prices fail to match global low-cost promise (March 18, 2026)